SWS Medical
Yubei
About SWS Medical
Founded in 2001, SWS Hemodialysis Care Co., Ltd. (“SWS”) has been committed to the field of blood purification for over two decades. We are committed to prioritizing patient welfare and ensuring the delivery of safe and effective products and services as part of our ongoing responsibility and mission. Through technological advancements and ongoing enhancements, it has established itself as the sole company in China's blood purification sector to possess a comprehensive dialysis industrial chain. SWS operates through four distinct segments: blood purification equipment, blood purification consumables, Advanced Hemodialysis Management System and chain dialysis centers. The organization is dedicated to delivering comprehensive medical solutions for patients with chronic kidney disease (CKD). SWS is publicly traded on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange under the ticker SSE: 688410. It proudly stands as the first company in China′s blood purification industry to achieve this listing. SWS operate three wholly-owned subsidiaries and a Sino-American joint venture, offering a comprehensive array of products that encompass all aspects of blood purification. - SWS Hemodialysis Care Co., Ltd. specializes in the manufacturing of equipment for blood purification - TWT Biotechnology Co., Ltd. specializes in the manufacturing of consumables for blood purification - Chongqing Kangmeijia Hemodialysis Co., Ltd. operates a network of dialysis centers - SD (Chongqing) Medical Equipment Co. Ltd. specializes in the production of high-quality dialyzers Innovation is at the core of SWS. Over the past two decades, SWS has developed key technologies, research methodologies and engineering solutions in the field of blood purification. We hold independent intellectual property, nearly 200 patents have been successfully granted. Recognized as a national demonstration enterprise for technological innovation, SWS has established national-level technology and engineering research centers as well as on-site postdoctoral workstation at national level. As a market leader in China, SWS has played a pivotal role in the establishment of three national standards and five industry-specific standards. Enhancing patient wellness is SWS’s top priority and ultimate goal.We are dedicated to providing better care through our on-going commitment to advanced integrated blood purification technologies. With thousands of units installed worldwide, countless patients suffering from kidney diseases have benefited from our high-quality products and customized services. SWS devices are CE marked, and our quality system holds ISO 13485:2016 certification. As a testament to our reliability, we have earned recognition as a trusted partner by top-tier Chinese Grade A hospitals and esteemed medical institutions across more than 80 countries and regions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Total funding: $33.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2017)
- Ticker: sse:688410
- Website: swsdialysis.com
- Phone: 023-6888-4702
Industries & Categories
Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sws-medical-36269 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.